Search Results 281-290 of 15266 for TNF
... TNF agents, and rituximab). Subjects with an MMT-8 score ≤ 66 (see Appendix B) must also have at least 2 other core set measures meeting the criteria ...
Tumor necrosis factor inhibitors within 12 weeks of screening; Leflunomide within 8 weeks of screening; Therapeutic pheresis within 4 weeks of Screening; Any ...
... TNF treatment, abatacept, alemtuzumab, IVIg, belimumab, tocilizumab, or eculizumab within 12 weeks prior to screening; For patients scheduled to receive ...
Received CD20 inhibitor, anti-tumor necrosis factor treatment, abatacept, alemtuzumab, any other experimental or biological therapy, intravenous ...
Prior therapy with an anti-programmed cell death (PD)-1, anti-PD-L1, anti-PD-L2, anti-tumor necrosis factor CD137, or anti-cytotoxic T-lymphocyte-associated ...
Effect of Anti-TNF Biologic Exposure During Pregnancy on Villitis of Unknown Etiology Diagnoses in Patients with Autoimmune Disease. Reprod Sci. 2024 Apr ...
Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.
... tumor necrosis factor (TNF) inhibitor, and/or interleukin 6 (IL-6) blockers. Any active autoimmune disease or chronic inflammatory condition, with the ...
The purpose of this study is to evaluate children ≥ 1 year of age and adults with neurofibromatosis type 1 (NF1) and plexiform neurofibromas treated with the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.